Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Ig-Innovations

Ig-Innovations Ltd is a brand new company with over 30 years experience in antibody production and immunoassay development. Confusing but true – the experience and expertise is in the people we employ not the name we give the company. Born-out of the acquisition of the diagnostics division of MicroPharm, Ig has captured the skills and expertise developed during the research and development of sheep derived polyclonal antibodies for human therapy (now FDA & MHRA licensed products), diagnostics and research.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Ig-Innovations
Gernos, Maesllyn, Llandysul, SA44 5LP
+44 (0)1239 858972
Contact Ig-Innovations
Website

 Latest Content from PMHub 

Webcast: Biosimilars: Friend or Foe to Healthcare?

White Papers and Resources | March 31, 2015 | Inizio

Understanding the opportunities for biosimilars and the threats to innovator biologics

Webinar: Understanding the patient journey in China

White Papers and Resources | March 31, 2015 | Inizio

The Chinese healthcare market is experiencing a period of great change. Utilising local knowledge and detailed case studies, this webinar examines the likely impact on the patient journey and considers...

Webinar: Capturing “in-the-moment” patient and physician insights

White Papers and Resources | March 27, 2015 | Inizio

Utilising the benefits of mobile technology

Webinar: Observational Research

White Papers and Resources | March 27, 2015 | Inizio

Presenting a window on the world of your customer

Webinar: The Brazil Conundrum

White Papers and Resources | March 27, 2015 | Inizio

Conducting research in one of the world's largest pharma markets

Webinar: Demand calibration: What’s inside the black box?

White Papers and Resources | March 27, 2015 | Inizio

The process of demand calibration of preference share (down-weighting) is often a proprietary "black box" technique, which can mean that the client is unsure how the calibrated figure has been...

Free Thinking: Behavioural economics

White Papers and Resources | March 27, 2015 | Inizio

Our Free Thinking white paper asks, does behavioural economic theory have a role to play in pharmaceutical market research?

Article: The Colombia Conundrum

White Papers and Resources | March 27, 2015 | Inizio

Published in eye for pharma 30 January by Marc Yates

Ageing in China: The Implications for Healthcare

White Papers and Resources | March 27, 2015 | Inizio

Published in eye for pharma 12 December by Marc Yates

5 years on from the Brazilian Generics Drugs Act, is there still an opportunity for branded originator drugs?

White Papers and Resources | March 27, 2015 | Inizio

Published in Eye for Pharma 10 November by Marc Yates